OrganiGram Holdings Stock (TSX: OGI) (NASDAQ: OGI) - Investor Dashboard
|Employees:||816 at 02/29/20|
OrganiGram Holdings – Management Team
Greg Engel – Director and Chief Executive Officer
Mr. Greg Engel has been appointed as Chief Executive Officer, Director of the Company, effective March 13, 2017. Engel has served in a number of senior-level and executive positions in related industries over the past 25 years in Canada, US and Internationally. Most recently he was chief executive officer for Tilray Canada Inc., an early medical marijuana leader and the first Canadian company to export medical cannabis products to Europe. Currently based in Toronto, Engel is familiar with Moncton having served as district sales manager in the pharmaceutical industry earlier in his career. Engel earned an Honours Bachelor of Science degree in Microbiology from the University of Guelph in 1987 and then studied marketing at Queen’s University. He has also attended York University’s Schulich School of Business.
Derrick West – Chief Financial Officer
Mr. West served as Chair of the Audit Committee of Organigram’s Board of Directors from December 2017 to February 2020 and also more recently, as a member of the Investment Committee. Mr. West was the Chief Financial Officer and Corporate Secretary of Partners REIT, an open-end real estate investment trust focused on managing a portfolio of retail community centres across Canada from 2014 until December 2019. He previously served as the Chief Financial Officer of Landdrill International, an international mining services Company with operations in Canada, Russia, Mongolia, and Mexico. Additionally, Mr. West served as the Vice-President of Accounting and Administration for Plazacorp Retail Properties Limited (renamed Plaza Retail REIT). Mr. West is a Chartered Professional Accountant and holds a Bachelor of Commerce degree from Mount Allison University.
Paolo De Luca, CA, CFA – Chief Strategy Officer
Mr. Paolo De Luca is Chief Strategy Officer of the Company. With more than 20 years of diversified financial business experience, Mr. De Luca has held senior financial, investor relations, and accounting leadership roles at companies including West Face Capital, one of Canada’s leading alternative asset management firms; Meridian LNG; Potash Ridge; C.A. Bancorp; and TD Securities. With this diverse industry and international background, he has extensive experience with both traditional and non-traditional financing and debt offerings. Mr. De Luca will be responsible for establishing and reviewing key strategic priorities and translating these into a comprehensive execution plan working with the Chief Executive Officer and the Board of Directors. This will include reviewing market trends, market size and outlook as well as our competitive positioning to identify profitable growth opportunities.
Ray Gracewood – Sr. Vice President of Marketing and Communications
Mr. Raymond Gracewood is the company’s Senior Vice President of Marketing and Communications. As the previous senior director of sales and marketing for Moosehead Breweries Ltd., Mr. Gracewood is a leading brand and marketing professional in Atlantic Canada. With more than 15 years of experience in the marketing space, he is a strong speaker on brand, packaging and positioning, both locally and throughout North America. He has extensive experience in building and developing brands, positioning and segmentation. Mr. Gracewood holds a bachelor of business administration from the University of New Brunswick.
James Cavanagh – Chief of Staff
Mr. James Cavanagh is the Chief of Staff at Organigram. Before his current position, he worked with PwC to oversee the implementation of manufacturing and sales processes. In his role as Chief of Staff, Mr. Cavanagh will help shape and guide the company’s strategy and resources.
Tim Emberg – Sr. Vice President of Sales and Commercial Operations
Mr. Tim Emberg is the Senior Vice President of Sales and Commercial Operations of the company. Mr. Emberg has a proven track record in healthcare and consumer packaged goods (CPG) having previously worked for Roche Canada, Jamieson Labs, and Frito-Lay Canada.
Significant Insider Ownership
Greg Engel, CEO
50K shares, 159K RSUs and 1.58 million warrants and options
Paolo De Luca, CSO
37K shares, 102K RSUs and 353K options and warants
Kenneth Mitton, Director
243K shares, 66K RSUs and 205K warrants and options
Peter Amirault, Director
150K shares, 69K RSUs and 154K warrants and options
Michael Bourque, Director
77K shares, 66K RSUs and 130K warrants and options
Ray Gracewood, COO
72K shares, 44K RSUs and 150K warrants and options
New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. OrganiGram Holdings is a client of NCV Media, LLC. Read our full disclaimer.